Cytotoxic activity of extracts of demosponges Haliclona caerulea, Axinella sinoxea and Ircinia mutans from Persian Gulf

249-253Sponges are valuable source of bioactive natural products. Although marine benthic invertebrate communities occur in the Persian Gulf they have been little explored for their biomedicinal potential. Here, we studied the methanol and diethyl ether extracts of sponges Haliclona caeralea, Axinella sinoxea and Ircinia mutans sponges for their cytotoxic activity against human epidermis carcinoma (KB/C152) and T-cell lymphoma cell lines (HUT-78/C185) cell lines. Sponges after collection and identification were extracted with methanol and diethyl ether extract. The cell viability and cytotoxicity induced by the extracts were assessed using XTT and lactate dehydrogenase release assays (LDH leakage). The results indicated that the methanol and diethyl ether extract of I. mutans exhibited strong cytotoxicity towards KB and HUT cell lines and diethyl ether extract of H. caeralea and A. sinoxea had significant cytotoxicity in HUT and KB cells compared to methanol extract. The results indicated that the methanol and diethyl ether extract of I. mutanspossess significant cytotoxic activity

Ispitivanje značajka domova djece s alergijskim rinitisom i astmom

The prevalence of allergic diseases, especially asthma and allergic rhinitis, has dramatically increased during the last decades. Mite and cockroach, which are the most common allergens in house dust, are the major indoor allergens in asthmatic and allergic rhinitis patients. The aim of this study was to compare the association between age of dwelling and some other home characteristics in asthmatic and allergic rhinitis children, who had positive skin prick test to mite and cockroaches, with allergic patient with negative skin test. Thirty-six asthmatic and allergic rhinitis children with positive skin prick test to mite and cockroach allergens, and 34 allergic rhinitis and asthmatic children with negative skin prick test to these allergens were enrolled in this study. Data on home characteristics, including age of homes, kind of carpeting, floor of home and number of rooms in the building, were collected by telephone questionnaire. The mean age of buildings was higher in the group of children sensitive to mite and cockroach (22.4±12.9 vs. 16.3±13.9 years), but the difference was not significant. However, when patients sensitive to mite only were compared to control patients, the difference was significant (p=0.025). There was no significant difference in the number of floor, rooms, kind of carpet and other features of building between the case and control group. There was a significant relationship between mite allergy and building age, which could be important for the policy of allergy control in the society. However, further studies are needed to clarify the association between more specific home characteristics and allergy diseases.Učestalost alergijskih bolesti, poglavito astme i alergijskog rinitisa, bilježi znatan porast posljednjih desetljeća. Grinje i žohari kao najčešći alergeni u kućnoj prašini glavni su alergeni na koje nailaze osobe s alergijom i alergijskim rinitisom u zatvorenom prostoru. Cilj ovoga istraživanja bio je usporediti povezanost starosti objekta i neke druge značajke domova kod djece s astmom i alergijskim rinitisom te s pozitivnim kožnim testom na grinje i žohare s vrijednostima istih kod djece s astmom i alergijskim rinitisom, ali s negativnim kožnim testom na grinje i žohare. U studiju je bilo uključeno 36 djece s astmom i alergijskim rinitisom te s pozitivnim kožnim testom na grinje i žohare i 34 djece s astmom i alergijskim rinitisom, ali s negativnim kožnim testom na grinje i žohare. Podatci o značajkama doma uključujući starost zgrade, vrst zidne obloge, kat i broj soba u zgradi prikupljeni su telefonskim anketiranjem roditelja. Srednja starost zgrade u kojoj žive bila je veća kod djece osjetljive na grinje i žohare nego u djece koja nisu pokazala osjetljivost na ove alergene (22,4±12,9 prema 16,3±13,9 years), ali razlika nije bila značajna. Međutim, kad su s kontrolnom skupinom uspoređena djeca osjetljiva samo na grinje, tada je razlika bila značajna (p=0,025). Nije bilo nikakve razlike između dviju skupina u odnosu na kat, broj soba, vrst zidne obloge i druge značajke zgrade. Dakle, utvrđena je značajna povezanost alergije na grinje i starosti zgrada, što bi moglo biti važno u planiranju aktivnosti za suzbijanje alergije u društvu. Potrebna su daljnja ispitivanja kako bi se pojasnila udruženost nekih specifičnih značajka zgrada i alergijskih bolesti

Molecular detection of Brucella species in patients suspicious of Brucellosis from Zanjan, Iran

Abstract Brucella is an intracellular pathogen capable of infecting animals and humans. The aim of this study was to identify Brucella spp in sera of high risk individuals by a polymerase chain reaction (PCR)-based method. A total of 180 patients suspected to have Brucellosis were examined by serological tests. To establish a PCR protocol for diagnosis of active brucellosis, DNA was extracted from the serum samples by using a commercial kit. PCR amplification was done for detection of Brocella DNA using BCSP31 target gene and IS711 locus. The PCR assay showed that an amplicon of 223 bp was obtained in 73.8% (133/180) of the tested sera using primers (B 4 /B 5 ) derived from a gene encoding the 31-kDa Brucella abortus antigen. In another PCR, an amplicon of 498 bp was obtained in 63.8% (115/180) of the samples using Brucella abortus-specific primers derived from a locus adjacent to the 3'-end of IS711, and also an amplicon of 731 bp was produced in 4.4% (8/180) of the tested samples using Brucella melitensis-specific primers. When the Wright method was used as a gold standard, the sensitivity and specificity of the PCR technique for genus identification were found to be 96 and 80.7%, respectively. However, the sensitivity value obtained with the species-specific PCR method was 82%, and specificity was similar to that previous reported. This is the first report of a high frequency of Brucella abortus in patients suspicious of Brucellosis from the Zanjan province

Priprava mikrokuglica s antigenom leptospira od biološki razgradivih alginatnih polimera.

Leptospirosis is a worldwide zoonosis caused by pathogenic Leptospira spp. Although the currently available whole cell leptospiral vaccines can induce protection against Leptospirosis, further study for a new generation of vaccine that can stimulate long-term immunity is needed. Biodegradable microspheres as antigen delivery systems have been extensively investigated for decades, especially those based on hydrophilic polymers, such as alginate and chitosan, which have excellent biocompatibility, non-toxicity and biodegradability. The aim of this study was to prepare and characterize alginate microspheres as an antigen delivery system for immunization against leptospirosis. Alginate microspheres containing Leptospiral antigen (LA) were prepared by an emulsification method and characterized for shape, size distribution, loading efficiency (LE), loading capacity (LC) and release profie. The effects of some parameters (such as concentration of alginate and emulsifiers and stirring rate) on microspheres characteristics were investigated. The optimal condition parameters for the preparation of LA loaded alginate microspheres were estimated. The optimum concentrations were obtained for alginate and emulsifiers, 3.5 % (w/v), span 80 (0.2 % w/v) and tween 80 (3.75 % w/v), respectively. Moreover, appropriate homogenizing rate was obtained at 500 rparticle size of the microspheres as 200 μm, loading efficiency 97 % and loading capacity 8 %. A suitable release profile was observed for in vitro release test of LA from alginate microspheres over an extended period of time (192 hours). These results make the alginate microspheres particularly interesting for an LA delivery system.pm. Our results showed the mean particle size of the microspheres as 200 μm, loading effiiency 97 % and loading capacity 8 %. A suitable release profile was observed for in vitro release test of LA from alginate microspheres over an extended period of time (192 hours). These results make the alginate microspheres particularly interesting for an LA delivery system.Leptospiroza je zoonoza prouzročena patogenim vrstama roda Leptospira, a proširena je diljem svijeta. Iako današnja cjepiva protiv leptospiroze, proizvedena od cijelih bakterijskih stanica, mogu pružiti zaštitu od leptospiroze, potrebna su daljnja istraživanja nove generacije cjepiva koja će moći potaknuti tvorbu dugotrajne imunosti. Biološki razgradive mikrokuglice istražuju se desecima godina kao mogućnost sporog otpuštanja antigena, a posebice su zanimljive one od hidrofilnih polimera kao što je alginat i kitosan, koji imaju izvrsnu biološku kompatibilnost, nisu toksični, a biološki su razgradivi. Svrha ovog rada bila je pripraviti alginatne mikrokuglice i odrediti njihova svojstva pogodna za otpuštanje antigena u postupku imunizacije protiv leptospiroze. Alginatne mikrokuglice s antigenom leptospira bile su pripravljene postupkom emulgacije te im je bio određen oblik, opseg distribucije, učinkovitost ugradnje antigena u mikrokuglice, kapacitet ugradnje i profil otpuštanja antigena. Istraženi su učinci nekih pokazatelja (kao što je koncentracija alginata i emulgatora te omjer miješanja) na obilježja mikrokuglica. Procijenjeni su optimalni uvjeti za pripravu alginatnih mikrokuglica na koje je vezan antigen leptospira. Optimalna koncentracija za alginat bila je 3,5 % (w/v), a emulgator span 80 (0,2 % w/v) i tween 80 (3,75 % w/v). Odgovarajuća homogenizacija postignuta je na 500 okretaja. Rezultati su pokazali da je srednja veličina mikrokuglica bila 200 μm, učinkovitost ugradnje antigena 97 %, a kapacitet 8 %. In vitro je ustanovljeno da se antigen leptospira oslobađao s alginatnih mikrokuglica tijekom 192 sata. Ti rezultati pokazuju da alginatne kuglice mogu biti od posebnog interesa za oslobađanje antigena leptospira u organizmu

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

BACKGROUND: The number of individuals living with dementia is increasing, negatively affecting families, communities, and health-care systems around the world. A successful response to these challenges requires an accurate understanding of the dementia disease burden. We aimed to present the first detailed analysis of the global prevalence, mortality, and overall burden of dementia as captured by the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, and highlight the most important messages for clinicians and neurologists. METHODS: GBD 2016 obtained data on dementia from vital registration systems, published scientific literature and surveys, and data from health-service encounters on deaths, excess mortality, prevalence, and incidence from 195 countries and territories from 1990 to 2016, through systematic review and additional data-seeking efforts. To correct for differences in cause of death coding across time and locations, we modelled mortality due to dementia using prevalence data and estimates of excess mortality derived from countries that were most likely to code deaths to dementia relative to prevalence. Data were analysed by standardised methods to estimate deaths, prevalence, years of life lost (YLLs), years of life lived with disability (YLDs), and disability-adjusted life-years (DALYs; computed as the sum of YLLs and YLDs), and the fractions of these metrics that were attributable to four risk factors that met GBD criteria for assessment (high body-mass index [BMI], high fasting plasma glucose, smoking, and a diet high in sugar-sweetened beverages). FINDINGS: In 2016, the global number of individuals who lived with dementia was 43·8 million (95% uncertainty interval [UI] 37·8-51·0), increased from 20.2 million (17·4-23·5) in 1990. This increase of 117% (95% UI 114-121) contrasted with a minor increase in age-standardised prevalence of 1·7% (1·0-2·4), from 701 cases (95% UI 602-815) per 100 000 population in 1990 to 712 cases (614-828) per 100 000 population in 2016. More women than men had dementia in 2016 (27·0 million, 95% UI 23·3-31·4, vs 16.8 million, 14.4-19.6), and dementia was the fifth leading cause of death globally, accounting for 2·4 million (95% UI 2·1-2·8) deaths. Overall, 28·8 million (95% UI 24·5-34·0) DALYs were attributed to dementia; 6·4 million (95% UI 3·4-10·5) of these could be attributed to the modifiable GBD risk factors of high BMI, high fasting plasma glucose, smoking, and a high intake of sugar-sweetened beverages. INTERPRETATION: The global number of people living with dementia more than doubled from 1990 to 2016, mainly due to increases in population ageing and growth. Although differences in coding for causes of death and the heterogeneity in case-ascertainment methods constitute major challenges to the estimation of the burden of dementia, future analyses should improve on the methods for the correction of these biases. Until breakthroughs are made in prevention or curative treatment, dementia will constitute an increasing challenge to health-care systems worldwide

Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Traumatic brain injury (TBI) and spinal cord injury (SCI) are increasingly recognised as global health priorities in view of the preventability of most injuries and the complex and expensive medical care they necessitate. We aimed to measure the incidence, prevalence, and years of life lived with disability (YLDs) for TBI and SCI from all causes of injury in every country, to describe how these measures have changed between 1990 and 2016, and to estimate the proportion of TBI and SCI cases caused by different types of injury. METHODS: We used results from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016 to measure the global, regional, and national burden of TBI and SCI by age and sex. We measured the incidence and prevalence of all causes of injury requiring medical care in inpatient and outpatient records, literature studies, and survey data. By use of clinical record data, we estimated the proportion of each cause of injury that required medical care that would result in TBI or SCI being considered as the nature of injury. We used literature studies to establish standardised mortality ratios and applied differential equations to convert incidence to prevalence of long-term disability. Finally, we applied GBD disability weights to calculate YLDs. We used a Bayesian meta-regression tool for epidemiological modelling, used cause-specific mortality rates for non-fatal estimation, and adjusted our results for disability experienced with comorbid conditions. We also analysed results on the basis of the Socio-demographic Index, a compound measure of income per capita, education, and fertility. FINDINGS: In 2016, there were 27·08 million (95% uncertainty interval [UI] 24·30-30·30 million) new cases of TBI and 0·93 million (0·78-1·16 million) new cases of SCI, with age-standardised incidence rates of 369 (331-412) per 100 000 population for TBI and 13 (11-16) per 100 000 for SCI. In 2016, the number of prevalent cases of TBI was 55·50 million (53·40-57·62 million) and of SCI was 27·04 million (24·98-30·15 million). From 1990 to 2016, the age-standardised prevalence of TBI increased by 8·4% (95% UI 7·7 to 9·2), whereas that of SCI did not change significantly (-0·2% [-2·1 to 2·7]). Age-standardised incidence rates increased by 3·6% (1·8 to 5·5) for TBI, but did not change significantly for SCI (-3·6% [-7·4 to 4·0]). TBI caused 8·1 million (95% UI 6·0-10·4 million) YLDs and SCI caused 9·5 million (6·7-12·4 million) YLDs in 2016, corresponding to age-standardised rates of 111 (82-141) per 100 000 for TBI and 130 (90-170) per 100 000 for SCI. Falls and road injuries were the leading causes of new cases of TBI and SCI in most regions. INTERPRETATION: TBI and SCI constitute a considerable portion of the global injury burden and are caused primarily by falls and road injuries. The increase in incidence of TBI over time might continue in view of increases in population density, population ageing, and increasing use of motor vehicles, motorcycles, and bicycles. The number of individuals living with SCI is expected to increase in view of population growth, which is concerning because of the specialised care that people with SCI can require. Our study was limited by data sparsity in some regions, and it will be important to invest greater resources in collection of data for TBI and SCI to improve the accuracy of future assessments

Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Background: Population estimates underpin demographic and epidemiological research and are used to track progress on numerous international indicators of health and development. To date, internationally available estimates of population and fertility, although useful, have not been produced with transparent and replicable methods and do not use standardised estimates of mortality. We present single-calendar year and single-year of age estimates of fertility and population by sex with standardised and replicable methods. Methods: We estimated population in 195 locations by single year of age and single calendar year from 1950 to 2017 with standardised and replicable methods. We based the estimates on the demographic balancing equation, with inputs of fertility, mortality, population, and migration data. Fertility data came from 7817 location-years of vital registration data, 429 surveys reporting complete birth histories, and 977 surveys and censuses reporting summary birth histories. We estimated age-specific fertility rates (ASFRs; the annual number of livebirths to women of a specified age group per 1000 women in that age group) by use of spatiotemporal Gaussian process regression and used the ASFRs to estimate total fertility rates (TFRs; the average number of children a woman would bear if she survived through the end of the reproductive age span [age 10–54 years] and experienced at each age a particular set of ASFRs observed in the year of interest). Because of sparse data, fertility at ages 10–14 years and 50–54 years was estimated from data on fertility in women aged 15–19 years and 45–49 years, through use of linear regression. Age-specific mortality data came from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 estimates. Data on population came from 1257 censuses and 761 population registry location-years and were adjusted for underenumeration and age misreporting with standard demographic methods. Migration was estimated with the GBD Bayesian demographic balancing model, after incorporating information about refugee migration into the model prior. Final population estimates used the cohort-component method of population projection, with inputs of fertility, mortality, and migration data. Population uncertainty was estimated by use of out-of-sample predictive validity testing. With these data, we estimated the trends in population by age and sex and in fertility by age between 1950 and 2017 in 195 countries and territories. Findings: From 1950 to 2017, TFRs decreased by 49\ub74% (95% uncertainty interval [UI] 46\ub74–52\ub70). The TFR decreased from 4\ub77 livebirths (4\ub75–4\ub79) to 2\ub74 livebirths (2\ub72–2\ub75), and the ASFR of mothers aged 10–19 years decreased from 37 livebirths (34–40) to 22 livebirths (19–24) per 1000 women. Despite reductions in the TFR, the global population has been increasing by an average of 83\ub78 million people per year since 1985. The global population increased by 197\ub72% (193\ub73–200\ub78) since 1950, from 2\ub76 billion (2\ub75–2\ub76) to 7\ub76 billion (7\ub74–7\ub79) people in 2017; much of this increase was in the proportion of the global population in south Asia and sub-Saharan Africa. The global annual rate of population growth increased between 1950 and 1964, when it peaked at 2\ub70%; this rate then remained nearly constant until 1970 and then decreased to 1\ub71% in 2017. Population growth rates in the southeast Asia, east Asia, and Oceania GBD super-region decreased from 2\ub75% in 1963 to 0\ub77% in 2017, whereas in sub-Saharan Africa, population growth rates were almost at the highest reported levels ever in 2017, when they were at 2\ub77%. The global average age increased from 26\ub76 years in 1950 to 32\ub71 years in 2017, and the proportion of the population that is of working age (age 15–64 years) increased from 59\ub79% to 65\ub73%. At the national level, the TFR decreased in all countries and territories between 1950 and 2017; in 2017, TFRs ranged from a low of 1\ub70 livebirths (95% UI 0\ub79–1\ub72) in Cyprus to a high of 7\ub71 livebirths (6\ub78–7\ub74) in Niger. The TFR under age 25 years (TFU25; number of livebirths expected by age 25 years for a hypothetical woman who survived the age group and was exposed to current ASFRs) in 2017 ranged from 0\ub708 livebirths (0\ub707–0\ub709) in South Korea to 2\ub74 livebirths (2\ub72–2\ub76) in Niger, and the TFR over age 30 years (TFO30; number of livebirths expected for a hypothetical woman ageing from 30 to 54 years who survived the age group and was exposed to current ASFRs) ranged from a low of 0\ub73 livebirths (0\ub73–0\ub74) in Puerto Rico to a high of 3\ub71 livebirths (3\ub70–3\ub72) in Niger. TFO30 was higher than TFU25 in 145 countries and territories in 2017. 33 countries had a negative population growth rate from 2010 to 2017, most of which were located in central, eastern, and western Europe, whereas population growth rates of more than 2\ub70% were seen in 33 of 46 countries in sub-Saharan Africa. In 2017, less than 65% of the national population was of working age in 12 of 34 high-income countries, and less than 50% of the national population was of working age in Mali, Chad, and Niger. Interpretation: Population trends create demographic dividends and headwinds (ie, economic benefits and detriments) that affect national economies and determine national planning needs. Although TFRs are decreasing, the global population continues to grow as mortality declines, with diverse patterns at the national level and across age groups. To our knowledge, this is the first study to provide transparent and replicable estimates of population and fertility, which can be used to inform decision making and to monitor progress. Funding: Bill & Melinda Gates Foundation